AITRICS

About

AITRICS is a South Korean company founded in 2016, specializing in the development of AI-based clinical decision support systems. Its flagship product, Vital Care, uses real-time electronic medical records (EMRs) to predict major adverse events in patients, such as sepsis, cardiac arrest, and death. By analyzing various data points, including vital signs, blood tests, and patient consciousness, AITRICS aims to enhance patient care through early intervention. The company has received significant funding, including a recent Series B round, to support its expansion into the U.S. market and further develop its AI capabilities. AITRICS collaborates with major hospitals and research institutions in South Korea, such as Korea University Anam Hospital and Asan Medical Center, to improve its predictive models and expand its clinical applications. The company has also partnered with Philips Korea to develop AI-based solutions for intensive care units. AITRICS's technology has shown promising results in clinical studies, predicting sepsis onset earlier than traditional methods. Its goal is to integrate its AI solutions seamlessly into existing healthcare systems, enhancing medical workflows and patient outcomes globally.